Therapy News and Research

RSS

Scott & White Healthcare teleconferences first live aortic aneurysm surgical procedures

Scott & White Healthcare today teleconferenced one of the world's first live international surgical procedures to repair an abdominal aortic aneurysm to conference attendees in Sao Paolo, Brazil.

22 Apr 2011

FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.

22 Apr 2011

Physiotherapy Associates inaugurates new clinic in Grand Haven, MI

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, recently opened a new physical therapy clinic in Grand Haven, MI.

22 Apr 2011

Acupuncture offers long-lasting relief for patients after prostate cancer treatment

Acupuncture provides long-lasting relief to hot flashes, heart palpitations and anxiety due to side effects of the hormone given to counteract testosterone, the hormone that induces prostate cancer, according to a study published in the April issue of the International Journal of Radiation Oncology-Biology-Physics, an official journal of the American Society for Radiation Oncology.

22 Apr 2011

Physiotherapy Associates inaugurates new clinic in Franklin, TN

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, recently opened a new physical therapy clinic at the Prairie Life Fitness Center in Franklin, TN. The clinic offers a comprehensive range of physical therapy services, including: outpatient physical therapy, sports rehabilitation, running gait analysis, and performance training.

22 Apr 2011

Convergence initiates CNV2197944 Phase I study in chronic pain

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated and dosing has begun.

22 Apr 2011

GM-SCF therapy can reduce flu symptoms and prevent death

New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor significantly reduces flu symptoms and prevents death after a lethal dose influenza virus.

22 Apr 2011

Roundup: Idaho Gov.'s exchange/health law decision; Calif. exchange board meets; Iowa mental health plan

Republican Gov. C.L. "Butch" Otter is no fan of the health care reform -- he was the first governor to sign legislation requiring his state to sue over President Obama's overhaul -- but said the bill state lawmakers passed in the 2011 session would have required Idaho to forego the creation of a state health insurance exchange.

22 Apr 2011

Discovery of cancer drugs to kill malaria parasite could open up new strategies for treatment

Ahead of World Malaria Day (25 April), EU-funded researchers have discovered that drugs originally designed to inhibit the growth of cancer cells can also kill the parasite that causes malaria. They believe this discovery could open up a new strategy for combating this deadly disease, which, according to World Health Organisation statistics, infected around 225 million and killed nearly 800 000 people worldwide in 2009.

21 Apr 2011

Thought leaders gather to examine challenges facing patients with primary immunodeficiencies

Thought leaders from the medical, scientific and patient advocacy communities gathered in New York and London for CSL Behring's Key Issues Dialogue–Immunoglobulin to examine challenges facing patients with primary immunodeficiencies.

21 Apr 2011

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.

21 Apr 2011

First UCLA patient with hand transplant doing well at six-and-a-half weeks

Six-and-a-half weeks after receiving the first hand transplant in the western United States, Emily Fennell is becoming so accustomed to her new right hand that she barely remembers when she didn't have one.

21 Apr 2011

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into a contract to supply a Gamma Knife® Perfexion™ system to Lovelace Medical Center in Albuquerque, New Mexico.

21 Apr 2011

BIOTONE launches Edu-Partner Community Outreach Award Program for fifth year

BIOTONE today launched its 2011 Edu-Partner Community Outreach Award Program. Now in its fifth year, the BIOTONE program awards two massage schools $2500 grants for their community volunteer massage therapy programs conducted during the year. BIOTONE will announce the 2011 recipients in early 2012.

21 Apr 2011

Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 positive patients

Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.

21 Apr 2011

Providing complete information about breast cancer treatment options often ends up overwhelming patients

Women who choose among different breast cancer treatment options make smarter choices when getting the information and making decisions in small doses rather than all at once, as is customary, a University of Michigan study found.

21 Apr 2011

Psoriasis patients still need long-established treatment alternatives

For patients with severe psoriasis, a new class of intravenous and injectable biological medicines known as "biologics" has brought about a near revolution in treatment.

21 Apr 2011

Genetic variation associated with MUC5B gene may increase risk of developing Pulmonary Fibrosis

A new discovery in a deadly lung disease may change the direction of research while uncovering increased risk for many patients and families. The Coalition for Pulmonary Fibrosis (CPF) and the Pulmonary Fibrosis Foundation (PFF) applaud the efforts of scientists that led to the discovery of a genetic variation associated with the MUC5B gene which may increase the risk of developing Pulmonary Fibrosis (PF).

21 Apr 2011

Nutlin-3a molecules stimulate signal to induce cell death and senescence in brain cancer

Researchers of Apoptosis and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL) have found that a small molecule, Nutlin-3a, an antagonist of MDM2 protein, stimulates the signalling pathway of another protein, p53.

21 Apr 2011

Alexion first quarter non-GAAP net income increases to $56.3 million

Alexion Pharmaceuticals, Inc. today announced financial results for the three months ended March 31, 2011. Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $166.1 million, reflecting steady additions of new patients, compared to $117.6 million for the same period in 2010.

21 Apr 2011

Therapy News and Research

Scott & White Healthcare teleconferences first live aortic aneurysm surgical procedures

FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer

Physiotherapy Associates inaugurates new clinic in Grand Haven, MI

Acupuncture offers long-lasting relief for patients after prostate cancer treatment

Physiotherapy Associates inaugurates new clinic in Franklin, TN

Convergence initiates CNV2197944 Phase I study in chronic pain

GM-SCF therapy can reduce flu symptoms and prevent death

Roundup: Idaho Gov.'s exchange/health law decision; Calif. exchange board meets; Iowa mental health plan

Discovery of cancer drugs to kill malaria parasite could open up new strategies for treatment

Thought leaders gather to examine challenges facing patients with primary immunodeficiencies

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

First UCLA patient with hand transplant doing well at six-and-a-half weeks

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

BIOTONE launches Edu-Partner Community Outreach Award Program for fifth year

Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 positive patients

Providing complete information about breast cancer treatment options often ends up overwhelming patients

Psoriasis patients still need long-established treatment alternatives

Genetic variation associated with MUC5B gene may increase risk of developing Pulmonary Fibrosis

Nutlin-3a molecules stimulate signal to induce cell death and senescence in brain cancer

Alexion first quarter non-GAAP net income increases to $56.3 million

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News